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ABSTRACT  
Calcium phosphates (CaP) are important biomaterials used in tissue engineering and drug 
delivery, due to their biocompatibility, low toxicity, and osteoconductivity. However, controlling 
the phase of CaP, especially tricalcium phosphate (TCP), is very challenging under mild 
conditions, particularly when using one preparation protocol for all CaP phases. It is also crucial 
to produce these biomaterials economically and reproducibly. Herein, three of the most 
commonly employed CaP, including beta-tricalcium phosphate (β-TCP), dicalcium phosphate 
anhydrous (DCPA), and hydroxyapatite (HA) were, for the first time, successfully synthesised 
by altering the reaction solvent, using calcium acetate monohydrate as a precursor and a rapid 
microwave-assisted synthetic method. A variety of CaP particle morphologies were obtained, 
including elliptical and plate-shaped with different porosities. Compared with conventional 
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heating, CaP biomaterials synthesised using microwave heating showed greater reproducibility, 
higher yields, and shorter reaction time. By varying the reaction solvents, morphologies and 
phases of CaP were controlled, leading to an enhanced protein bovine serum albumin (BSA) 
loading, with a higher BSA absorption observed according to the trend DCPA> β-TCP > HA. 
Furthermore, the phase, specific surface area and pores size were shown to play decisive roles in 
protein desorption with a higher release amount observed according to the trend DCPA > β-TCP 
> HA. Finally it is found that larger pores are also beneficial to BSA adsorption. 
INTRODUCTION 
Calcium phosphates (CaP) are a group of inorganic compounds present in mammalian 
bone and teeth. They have gained increasing interest in bone regeneration and drug delivery, 
owing to their  low toxicity, excellent biocompatibility, nonimmunogenicity and osteoconductive 
properties.
1,2,3,4,5
 CaP materials are used in a wide range of biomedical products such as coatings 
on orthopaedic and dental implants, prosthetic coatings and composites, as well as scaffolds for 
bone regrowth, depending on their resorbability and bioactivity.
6,7
 For instance, the least soluble 
CaP phase, hydroxyapatite (HA), is widely applied as a coating in orthopaedic and dental 
implants, and in liquid chromatography of biological compounds due to chemical similarities to 
the minerals in bone and teeth. On the other hand, other CaP phases such as beta-tricalcium 
phosphate (β-TCP) and dicalcium phosphate anhydrous (DCPA), which exhibits a higher 
aqueous solubility and hence resorption rate compared with HA, can also act as a degradable 
drug carrier and scaffold material. 
2,8 
Finally, the most important advantage of CaP biomaterials 
is that their degradation in the human body does not create any toxic substances compared to 
some polymers (e.g. polycaprolactone).
9
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Formation of CaP phases relies on the presence of components from orthophosphoric 
acid (H3PO4), i.e. H2PO4
- 
,  HPO3
2-
 , or PO4
3-
 ions.
10
 β-TCP [Ca3(PO4)2] , DCPA [CaHPO4] and 
HA [Ca10(PO4)6(OH)2], possessing Ca/P ratios ranging from 1 to 1.67, are amongst the most 
useful calcium phosphate phases in the biomedical field. Acidity and solubility of these CaP 
materials are inversely related to the Ca/P ratio. Hence, the relative solubility of these phases is 
as follows; DCPA > β-TCP > HA. 11,12 
 
CaP compounds can be categorized into (i) low-temperature CaP and (ii) high-
temperature CaP, where the former can be formed in an aqueous solution at low temperature and 
is a potential precursor for the high-temperature phases (e.g. β-TCP and HA).12 On the other 
hand, synthesis of β-TCP typically requires reaction temperatures above 700-800 ˚C.5 Generally, 
it is a two-step reaction, firstly either the calcium deficient hydroxyapatite (CDHA) or an 
intermediate phase (amorphous calcium phosphate) is obtained before transforming into β-TCP 
when increasing in the reaction time.
13,14
 Several low-temperature methods have been  studied to 
synthesise the high-temperature CaP phases, including both β-TCP and HA, but at the cost of 
exponentially increasing the reaction time (e.g. more than 8 hours to crystallise β-TCP particles) 
and subsequent control of particle shape is generally poor.
14
 Hence, the synthesis of different 
CaP phases with a high yields under mild reaction conditions still remains a challenge.  
 
By using microwave-assisted synthesis, various CaP phases can be targeted using an 
identical preparation pathway as developed in this study. Microwave heating is based on 
dielectric heating where the heat is generated internally due to the rotation, friction and collisions 
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of molecules as the permanent dipole moment of solvent molecules attempts to align with the 
applied electromagnetic field. It can allow the low temperature and fast production of crystalline 
particles with controlled morphology, high yields and heating rates, better selectivity and 
improved reproducibility. 
15,16,17,18
 The heating rate and efficiency of microwave heating depends 
on the nature of the coupling of the reaction mixture with the microwave field (tan δ). Therefore 
in this study, strong microwave absorbing solvents, (i.e. methanol, ethanol and water) were used 
to allow fast and homogeneous heating during the reaction. Various CaP, from low temperature 
to high temperature phases (e.g. β-TCP, DCPA and HA), were successfully fabricated without 
any additional surfactants. As a result, no additional steps were required to remove the 
surfactants, simplifying the synthesis process and lowering the cost. Interestingly, calcium 
acetate monohydrate was found to be a suitable precursor for the synthesis of different phases of 
calcium phosphates under identical mild experimental conditions, which could not be achieved 
by other precursors (for example, calcium nitrate tetrahydrate and calcium hydroxide).
19
  
 
CaP materials are widely used as drug carriers and non-viral gene carriers. Systematic 
delivery of drugs in the human body suffers from problems associated with enzymatic 
degradation and adverse effects when traveling in human blood.
20
 Conversely, localised delivery 
of therapeutics using CaP nanovectors can offer reduced toxicity and improved efficacy. For 
instance, a combination of CaP bioceramics and proteins, e.g. bone morphogenetic proteins or 
fibronectin, can notably improve the osteogenic potential of bone substitutes and reduce the 
recovery period by enhancing the osteoblastic differentiation.
21
 Nano-sized CaP particles are 
highly interesting drug delivery agents, as their higher specific surface areas provide increased 
carrier sites. Furthermore, nanocarriers can significantly overcome the limitations of direct 
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delivery by reducing the possibility of enzymatic degradation and possible hazardous side 
effects.
20 
In addition, nano-sized CaP particles more closely mimic the natural bone 
nanostructure and induce bone regrowth more effectively.
22
 Hence, increasing efforts have been 
made to control the particle size, porosity, shape, surface structure and internal structure of CaP 
nanomaterials to improve drug carrier properties. However, control over the loading capacity and 
release properties still remain an important challenge in the biomedical area.
2
 The efficacy of 
these carriers for drug delivery is strongly dependent on the ability to bind the drug effectively, 
which is dominated by electrostatic forces between the drug molecules and the material surface.
7
 
In addition, controlling material morphology and porosity can provide the desired surface area 
for optimum adsorption of drug molecules.
23
 Thus, by tuning the phase and morphology of CaP, 
control of protein loading and release rate should be possible. Therefore this study focuses on the 
control of phase, morphology and porosity of CaP by a facile route, in an attempt to manipulate 
the drug adsorption and release properties of these highly biocompatible materials. 
 
EXPERIMENTAL SECTION 
Synthesis: Preparation of CaP nanomaterials was prepared using modified literature procedures.
2
  
For β-TCP preparation, 0.79 g of Ca(C2H3O2)2•H2O  (Sigma) and 0.33 g of H3PO4 (Acros 
Organics) were each dissolved in 20 mL methanol, at room temperature. The H3PO4 solution was 
added drop-wise to the Ca solution, then transferred into a sealed PTFE container equipped with 
a stirrer bar, before inserting into the microwave (MARS, CEM). The hydrothermal/solvothermal 
reaction was pre-set to 25 minutes of ramping time and 5 minutes of holding at 200 ⁰C. The 
output power of microwave was adjusted automatically to maintain the temperature and ramp 
rate. Finally, the suspended product was separated and purified by centrifugation and washed 
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several times with ethanol before drying at 70 ºC for 12 h. The procedure was repeated by 
replacing methanol with ethanol and water for preparation of DCPA and HA, respectively. 
 
Characterisation: Phase identification by PXRD was carried out using a Bruker D8 Advance 
Powder X-ray Diffractometer with a CuKα (λ = 0.154060 nm) radiation source. Diffraction 
patterns were collected from 10 º to 80 º with a step size of 0.02 º and 10 seconds of step time. 
These patterns were compared with the standard spectra from the JCPDS database. Raman 
spectra data were acquired using a Renishaw Raman Microscope with helium-neon laser at a 
wavelength of 514.5 nm. Morphologies of samples were observed using a 2x JEOL 1010 
Transmission Electron Microscope (TEM) and JEOL 7401 high resolution Field Emission 
Scanning Electron Microscope (SEM) which was operated at 2 kV. In order to improve the SEM 
image quality, the powder samples were pretreated by Au coating.  
 
Protein/BSA loading and release: Bovine serum albumin (BSA) was used to study in vitro 
protein loading and releasing profile. The loading and release experiments were conducted as 
previously reported.
2
 Briefly: 0.25 g of CaP sample was added to 50 ml of BSA solution 
(1mg/mL) and then stirred for 24 hours at room temperature. The BSA loading amount was 
calculated based on the depletion of BSA in the solution measured by UV-Vis spectroscopy 
(Shimadzu UV2550 in the 277-280 nm range). 0.25 g of loaded sample was then incubated in 10 
mL of phosphate buffer solution at room temperature. 2 mL aliquots of solution were removed 
and then replaced with fresh buffer solution at pre-set time intervals. The BSA concentration at 
different time points was measured by UV-vis. A baseline with water or phosphate buffer was 
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performed before each measurement. A calibration plot (0.1-1 mg/mL) using known BSA 
concentrations was undertaken to calculate the concentrations of the loading and release samples.  
 
RESULTS AND DISCUSSION 
Analysis of Calcium Phosphates 
A rapid and homogeneous microwave heating method was chosen in this study to 
enhance the selectivity of CaP phases and control particle morphology. This unique chemical 
method produced high yields of three important CaP phases, including β-TCP, DCPA and HA, 
by altering the solvent and using calcium acetate monohydrate as a precursor (calcium nitrate 
tetrahydrate and calcium hydroxide did not yield β-TCP under similar experimental condition, 
XRD pattern not shown herein). The chemical reactions occurring in this study are based on the 
acid-base reaction, (i.e. acidic phosphoric acid with basic calcium acetate), but β-TCP is the 
neutral phase, whilst DCPA and HA are slightly acidic and basic, respectively. 
24
 Initially, CaP 
biomaterials were synthesised via microwave irradiation at 200 ˚C, using a 5 minute reaction 
time. As depicted in Figure 1, a different CaP phases were obtained using different solvents 
while keeping the same precursor Ca/P molar ratio constant and without adjustment in pH. All 
XRD patterns were matched with JCPDS database; β-TCP (JCPDS #09-0169), DCPA (JCPDS 
#9-80), HA (JCPDS #09-0432) or brushite (JCPDS #09-0077).  
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Figure 1. XRD patterns of CaP phases (β-TCP in methanol, DCPA in ethanol and HA in water) 
prepared at 200 ⁰C for 5 minutes via the microwave method.  
 
The synthesised CaP particles appear to have a preferred growth orientation according to 
the solvent used, resulting in a variation in morphology, observed by TEM (Figure 2). After a 
reaction time of five minutes, DCPA particles were found to be elliptical with a dimension of 50-
110 nm x 40-90 nm, HA materials were plate-like in shape (1-5 µm x 0.4-1.2 µm), while β-TCP 
were needle-shaped nanoparticles with a 20-80 nm x 10-20 nm. Short reaction times resulted in 
low yields, for example, less than 10 % β-TCP was produced when the reaction time was 5 
minutes. However, when the microwave reaction time further increased to one hour, no change 
in calcium phosphate phase was found (as verified through XRD, see Supporting Information, 
S1), but the longer reaction time increased the yield and also changed the morphology (Figure 3 
and Supporting Information, S2). A narrow particle size distribution of β-TCP nanoparticles was 
observed for the sample synthesised for 30 minutes (Supporting Information, S3), however the 
yield was still low at 24%. After one hour, β-TCP nanoparticles grew from needle-shaped to 
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elliptical with dimensions 50-120 nm x 40-80 nm and a porous surface (Figure 3). DCPA 
particles transformed from elliptical into larger flat plate-like particles with dimensions of 140-
950 nm x 100-240 nm. The shape of HA particles did not change but they increased in 
dimensions to 2-10 µm x 0.4-2 µm. When the reaction time was further increased to two hours, 
the yield of the CaP nanoparticles was similar to that achieved after one hour reaction time, 
implying that the reactions achieved equilibrium after 1h. Therefore, it can be concluded that the 
optimum synthesis conditions are a temperature of 200 ˚C with one hour of residence time in the 
microwave, resulting in a high yield of CaP materials, (e.g. 80.72 % for β-TCP. 85.11 % for 
DCPA and 91.99 % for HA).   
 
 
   
Figure 2. TEM images of (a) needle-like β-TCP nanoparticles, (b) elliptical DCPA particles and 
(c) plate-like HA particles synthesised after 5 minutes microwave heating at 200 ⁰C. 
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Figure 3. TEM images for (a) β-TCP nanoparticles, (b) DCPA and (c) HA particles produced 
using microwave heating at 200 ⁰C for one hour.  
 
The high yield of all three phases of CaP indicates that the temperature was high enough 
to provide sufficient energy not only to drive the reaction, but also to drive it to completion. The 
Raman Spectra of β-TCP, DCPA and HA samples are similar to the literature (Supporting 
information, S4).
 25,26,27,28
 Raman peaks at 291, 404, 470, 548, 611, 631, 734, 948, 967 and 1005 
cm
-1 
correspond to those found in β-TCP, while characteristic Raman peaks of DCPA were seen 
at 392, 419, 562,576, 591, 901, 987 and 1097 cm
-1
.
 25, 27,28 
 HA only has four main Raman peaks, 
which are found at 430, 592, 962 and 1046 cm
-1
. 
25,26
  
 
Table 1. Specific surface area, product yield and weight percentage of BSA loaded onto different 
CaP surfaces (β-TCP, DCPA and HA) obtained at 200 ˚C and one hour reaction time.  
Type of 
solvent 
Phase Yield (%) BET Specific 
Surface Area (m
2
/g) 
BSA Loading 
(wt.%) 
Methanol β-TCP 80.72 34.4 41 
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Ethanol DCPA 85.11 77.8 50 
Water HA 91.99 16.1 15 
 
The mesoporosity of β-TCP, DCPA and HA particles (prepared at 200 ˚C with one hour 
holding time) was further analysed by nitrogen adsorption/desorption analysis. DCPA shows a 
type IV isotherm indicative of a mesoporous material, with a relatively narrow distribution of 
pore diameters as shown by the sharp peak in the range of 4-12 nm in the BJH plot (Figure 4). β-
TCP nanoparticles exhibit a similar type IV isotherm but a larger pore size of 10-40 nm. Only 
HA particles obtained in this study show a type II isotherm with zero pore volume, indicating 
that they are nonporous. Regarding the specific surface area, DCPA particles have the largest 
specific surface area (77.8 m
2
/g), followed by TCP (34.4 m
2
/g) and then HA particles (16.1 m
2
/g) 
(see Table 1), consistent with their pore volume.  
 
 
Figure 4. Pore size distribution and N2 adsorption-desorption equilibrium isotherm of β-TCP, 
DCPA and HA particles formed at 200 ⁰C and one hour residence time in microwave.  
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Phase Selection of Calcium Phosphates 
Chemical reactions in microwave synthesis are highly dependent on the nature of reaction 
solvent. No reaction occurred in both alcohol solvents (methanol and ethanol) before microwave 
irradiation due to the low solubility of calcium precursors in alcohols, while brushite directly 
formed after mixing both precursors in water (Supporting information, S5). Reactions in 
methanol (Equation 1a and 1b), ethanol (Equation 2) and water (Equation 3a and 3b) are shown 
below: 
 
𝐶𝑎(𝐶𝐻3𝐶𝑂𝑂)2 +  𝐻3𝑃𝑂4  → 𝐴𝐶𝑃 +  2𝐶𝐻3𝐶𝑂𝑂𝐻      (1a) 
𝐴𝐶𝑃 →  𝐶𝑎3(𝑃𝑂4)2          (1b) 
𝐶𝑎(𝐶𝐻3𝐶𝑂𝑂)2 +  𝐻3𝑃𝑂4  → 𝐶𝑎𝐻𝑃𝑂4 + 2 𝐶𝐻3𝐶𝑂𝑂𝐻     (2) 
𝐶𝑎(𝐶𝐻3𝐶𝑂𝑂)2 +  2 𝐻2𝑂 +  𝐻3𝑃𝑂4  → 𝐶𝑎𝐻𝑃𝑂4 • 2 𝐻2𝑂 + 2 𝐶𝐻3𝐶𝑂𝑂𝐻   (3a) 
𝐶𝑎𝐻𝑃𝑂4 • 2 𝐻2𝑂 →  𝐶𝑎10(𝑃𝑂4)6(𝑂𝐻)2                                                                               (3b)        
 
β-TCP and HA follow a two-step reaction sequence. Bow et al. reported that amorphous 
calcium phosphate (ACP) is initially obtained through mixing these two precursors at room 
temperature using methanol as a solvent.
14
 After undergoing microwave dielectric heating, the 
non-crystalline ACP is transformed into a crystalline CaP (β-TCP) in methanol with acetic acid 
as the by-product (Equation 1a and 1b). In water, brushite immediately precipitated (Equation 
3a) after addition of the phosphoric acid into the calcium precursor solution and acted as the 
precursor to HA (Equation 3b). 
7
 Indeed, water is always needed in the chemical transformation 
of brushite, therefore, it is hydraulic compared to other phases.
24
 For DCPA, no initial phase was 
formed when mixing the two precursors at room temperature (as found by XRD-not reported 
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herein) as calcium acetate is totally insoluble in ethanol at room temperature. However, after 
microwave assisted heating, slow dissolution and calcium ion release allowed the formation of 
DCPA (Equation 2).  
 
Microwave heating in a closed vessel system produces a high vapour pressure that can 
further facilitate CaP nucleation and growth. For example, methanol is a highly volatile organic 
solvent. Hence, it produced the highest vapour pressure, 400-550 psi, followed by ethanol with 
approximately 300-400 psi and water at 110-200 psi (measured by a pressure probe located in 
the cavity of the microwave reaction system -see Supporting Information, S6). However, the 
vapour pressure of the solvents does not play a decisive role in the final product phase formed 
but may contribute in combination with microwave heating to accelerate the reaction rate, as  β-
TCP, DCPA and HA can be synthesised at room temperature in similar solvents but with an 
extended reaction time. 
14,29,30
 For instance, synthesis of both β-TCP and DCPA require five 
minutes microwave irradiation instead of approximately eight and three hours, respectively at 
room temperature. 
14,30
 Furthermore, reducing the reaction temperature of microwave assisted 
synthesis to ca. 70 ˚C did not produce any β-TCP in five minutes. Therefore, the rapid synthesis 
and phase selectivity of CaP biomaterials is the product of both a highly pressurized system and 
rapid heating associated with our microwave assisted synthesis.  
 
Table 2. Dissipation factors (tan δ), pKa of phosphoric acids in solvents and polarity data for 
methanol, ethanol and water. 
31,32,33
 
Solvents pKa Polarity index tan δ (x10
-4
) 
Methanol 5.15 5.1 6400 
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Ethanol 6.15 5.2 2500 
Water 2.11 9.0 1570 
 
By excluding the aforementioned factors, solubility of precursors in different solvents 
(Table 2) plays a critical role in controlling the phase of calcium phosphates and morphology. 
The nucleation rate of CaP is determined by the concentration of calcium and phosphate ions in 
solution. 
24
 This concentration is dependent on the solubility of precursors (calcium acetate 
monohydrate and phosphoric acid) in the different reaction solvents. The calcium and phosphate 
ions, from calcium acetate monohydrate and phosphoric acid, interact chemically and precipitate 
as the end product or form the intermediates for additional CaP phases. For instance, brushite 
which precipitated before microwave heating acts as an intermediate precursor for HA in water. 
Water is a highly polar solvent, so the degree of dissociation of both precursors is relatively 
higher. For example, calcium acetate monohydrate dissolves in water, but only partially 
dissolves in alcohols at room temperature.
34
 Consequently, the higher solubility of precursors in 
water leads to the insoluble HA phase produced in water. Furthermore, the pKa value in water 
(pKa=2.11) indicates a higher dissociation of phosphoric acid than in alcohol (pKa = 5.15-6.15), 
which shifts the reaction from left to right (Equation 4) and more H𝑃𝑂4
2− ions favour brushite 
and then HA formation in water.
35
  
 
𝐻3𝑃𝑂4  ⇌  𝐻2𝑃𝑂4
− ⇌ 𝐻𝑃𝑂4
2− ⇌  𝑃𝑂4
3−       (4) 
 
In addition, Ca/P ratio of these phases and the solubility of precursors are intimately related. 
Indeed, the use of alcohols tends to reduce the Ca/P ratio of the final CaP phase.
36
 Based on 
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Table 1, HA, with the highest Ca/P ratio, was prepared in water because the degree of 
dissociation of both precursors in water are relatively higher than both in alcohols, and OH
-
 ions 
were present in water. Calcium acetate monohydrate is slightly soluble in methanol and almost 
insoluble in ethanol, hence, the Ca
2+
 ion concentration in ethanol at room temperature would be 
lower than in methanol. Amorphous calcium phosphate, with Ca/P molar ratio of 1.2-2.2, was 
obtained when mixing the two precursors in methanol after a few hours at room temperature. 
14,37
 
Therefore, β-TCP preferably forms in methanol due to slightly higher concentration of calcium 
ions than in ethanol in which DCPA with a low Ca/P ratio of 1.00 was produced.   
 
Morphology Control of Calcium Phosphates 
 
The morphology of CaP produced was strongly influenced by the type of reaction 
solvent. Solute-solvent interaction can change the crystal growth kinetics and surface energy, 
thus enhancing or inhibiting growth at certain crystal faces.
38,39
 Reardon et al. reported that the 
morphology evolution of CaP materials relied on the concentration of the residue precursors in 
the solution after the formation of nuclei; a higher precursor concentration favours one-
dimensional growth and a lower precursor concentration allowed three-dimensional growth of 
nanocrystals.
17
 A measure of the efficiency of a solvent to convert the absorbed microwave 
energy to thermal energy is known as the dissipation factor tan δ, as listed in Table 2; higher tan 
δ values indicates greater heat dissipation to the solvent molecules, allowing a more rapid 
achievement of the desired temperature.
33
 Therefore, a faster heating and higher vapour pressure 
produce an environment in which nucleation is faster, in the order methanol > ethanol > water. 
Larger amounts of nuclei which form decreases the precursor ion concentration or the chemical 
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potential in alcoholic solvents, thus favouring three-dimensional growth of crystals and leading 
to small needle-shaped β-TCP and elliptical DCPA particles in methanol and ethanol, 
respectively. Inversely, a high precursor ion concentration in water resulted on a preference for 
one-dimensional growth.
17
 Furthermore, the reaction time also affected the size and morphology 
of the crystals; larger crystals were obtained with longer reaction times. As the reaction time was 
extended, the needle-shaped β-TCP particles transformed into regular elliptical shapes in 
methanol, DCPA agglomerated into larger plate shapes in ethanol (some smaller particles still 
can be seen in Supporting Information, S2). HA retained its morphology but increased in size.  
 
Protein Loading and Release 
 
The loading efficiency of therapeutic agents and general bioactivity were studied using 
bovine serum albumin (BSA) as a model protein. BSA loading was carried out for 24 hours to 
ascertain the drug delivery performance of the CaP biomaterials. The specific surface area and 
pore size of CaP materials influenced the protein adsorption capacity. Table 1 displays the 
amount of BSA adsorbed onto the three CaP materials. DCPA particles have the largest specific 
surface area (77.8 m
2/g), followed by β-TCP (34.4 m2/g) and then HA particles (16.1 m2/g) as 
shown in Table 1, consistent with their pore volume. The micron plate-shaped HA particles 
prepared in water as a solvent showed a 15 wt% BSA loading due to its comparatively small 
surface area of 16.1 m
2
/g. A threefold increase in loading efficiency for DCPA particles 
compared to HA particles was found, which correlates with the 380 % increase in surface area 
and higher meso-porosity observed. β-TCP particles represent a 41 wt% loading of BSA, only 18 
wt% less than DCPA although its surface area is 2 times smaller than DCPA. 
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The adsorption of BSA molecules onto CaP particle surfaces is mainly driven by the 
electrostatic interaction between the charged amino acids in the BSA molecule and the CaP 
particle surface where the highly ionic CaP surface exerts greater electrostatic forces to interact 
with the functional groups in BSA molecules. 
20,40,41
 Specifically, this interaction occurs between 
Ca
2+
 in the CaP and COO
-
 in BSA molecules. A higher surface area increases the overall charge 
per unit weight (more Ca
2+
 ions on the surfaces) which results in a higher degree of electrostatic 
interaction between CaP and BSA.
20 
Therefore, the smallest surface area HA with fewest Ca
2+ 
adsorption sites on the surface adsorbed the least amount of BSA molecules. Zhu et al. reported 
that greater amounts of protein adsorbed onto porous surfaces, concluding that the higher 
porosity produced more binding sites,
21
 and is in agreement with our results- highly porous 
DCPA adsorbs the highest amount of BSA.
 
It was also reported that the pore size also affects the 
BSA adsorption capacity; large mesopores allow more large biomolecules such as BSA 
(ellipsoid with dimensions 14 nm x 3.8 nm x 3.8 nm) to be adsorbed.
23,42,43
 The β-TCP material 
has less than half the surface area of the DCPA sample, but demonstrated ca. 82% of the BSA 
loading amount achieved by DCPA. This strongly indicates that the mesoporous structure of β-
TCP (15-40 nm) can host more BSA molecules in comparison to the smaller pores (4-12 nm) in 
DCPA. Conversely, HA has the smallest surface area and a nonporous structure, resulting in the 
smallest loading amount of BSA. This characteristic suggests that drug loading may be 
controlled by not only surface area but also pore size. 
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(a) (b) 
Figure 5. Protein release profile for: (a) Cumulative BSA release (wt%) using different CaP (β-
TCP, DCPA and HA) based on loading efficiency. (b) Cumulative amount of protein release 
(mg) from β-TCP, DCPA and HA surfaces over 96 hours. All the CaP samples were synthesised 
at 200 ⁰C, with one hour of microwave heating.  
 
The other important aspect of a drug delivery medium is its release profile. The BSA-
loaded CaP samples were incubated in vitro to examine this property. All the materials exhibit a 
two-stage release profile (Figure 5 (a) and (b)) consisting of an initial fast release stage (0-10 
h), followed by a slow linear release stage (10-96 h). Based on Figure 5(a), the BSA released 
(wt%) over the whole delivery period was the largest for HA, in comparison, DCPA exhibited 
the smallest release (wt%), regardless of loading amount. It was found that 62 wt% of BSA (4.7 
mg) was released from HA, 40 wt% (8.2 mg) from β-TCP and only 31 wt% (7.8 mg) of BSA 
from DCPA particles after the first 10 hours (Figure 5(b)). According to Figure 5 (a) and (b), the 
BSA released (in wt % and mg) on three samples at the second stage are much slower compared 
with the first stage. It is estimated 100% of the protein would be released after 7 and 9 days from 
the β-TCP and DCPA particles respectively; in contrast to just 6 days for HA, which could be 
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due to its lower adsorption capacity. During the second release phase (10-96 h), DCPA shows 
the largest release amount of BSA (15.4 mg), compared to 15.2 mg for β-TCP and only 6.7 mg 
for HA. The total amount of BSA released from DCPA is expected to surpass β-TCP after 96 
hours (Figure 5(b)).  
 
The two-stage release mechanism for all CaP phases is determined by the physical states 
of the adsorbed molecules and dissolution rate of CaP material. 
20,21,44
 The fast initial release is 
attributed to loosely bonded BSA molecules (physical adsorbed molecules) present on the outer 
adsorption layers where the electrostatic forces are weak and dominated by surface area. The 
increase in the thickness of BSA layers on the CaP surfaces results in the molecules not being 
tightly bound. The second release stage is dominated by the dissolution rate of CaP; higher 
solubility of CaP has a higher dissolution rate, enabling a higher amount of the BSA to be 
released (Figure 5(b)).
20
 Thus, the protein release amount is directly linked to CaP solubility: 
DCPA > β-TCP > HA. However, another important influence of protein release rate is the pore 
size in which the BSA molecules are captured. Gao et al. reported that the drug molecules easily 
leaked out or released from the larger pore surfaces.
43
 Therefore, the larger pores of β-TCP can 
also explain the higher release amount of BSA compared to DCPA over the same release period. 
Therefore, it can be concluded that the release profile is affected by a trifecta of surface area, 
CaP dissolution rate and pore size.  
 
CONCLUSIONS 
In summary, morphology controlled CaP materials (β-TCP, DCPA and HA) have been 
successfully synthesized in high yield (>80%) using rapid microwave-assisted synthesis under 
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mild processing conditions and short reaction times without addition of any surfactants. 
Furthermore, calcium acetate monohydrate was found to be the only suitable precursor to prepare 
different phases of CaP. The CaP phases formed were shown to be controlled by the type of 
solvents used rather than the Ca/P molar ratio, as well as residence time and reaction 
temperature/vapor pressure of solvents. This was attributed to the solubility of the precursors and 
polarity index of solvents. The efficacy of CaP biomaterials as drug carriers is strongly linked to 
their specific surface area and pore size. Increasing the specific surface area provides more 
binding sites; DCPA particles represented the highest loading amount of BSA (50 wt%) in our 
study. The elliptical β-TCP nanoparticles exhibited a 41 wt% BSA loading, a 2.7 times 
enhancement in BSA loading capacity compared with the lowest surface area plate-shaped HA 
materials.  
 
Interestingly, mesopores were formed in β-TCP and DCPA during preparation in alcohol 
solvents (methanol and ethanol) and resulted in higher BSA loading, demonstrating that the pore 
size also affects the loading capacity, with the larger pore size (similar to the size of BSA) of β-
TCP increasing the adsorption of BSA macromolecules (cage effect).  
 
Furthermore, the release of BSA from different CaP were characterised by a two-stage 
profile and were controlled by the surface area, dissolution rate of CaP and pore size. A higher 
dissolution rate of CaP facilitated a larger BSA release amount. Importantly, the larger pores in 
the β-TCP material may also influence the higher release amount of BSA compared to DCPA 
(smaller pore size) over the same release period. In short, the phase and morphology-controlled 
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CaP materials provide a platform to readily control both the drug delivery profile and loading 
capacity of proteins.  
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